BISACODYL
-
bisacodyl suppository
CARDINAL HEALTH, INC.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
For the relief of occasional constipation. Bowel movement is generally produced in 15 minutes to 1 hour.
For rectal use only
Do not use
laxative products for a period longer than one week unless directed by a doctor
Ask a doctor before use if you have
• abdominal pain, nausea or vomiting
• a sudden change in bowel habits that lasts longer than 2 weeks
Stop use and ask a doctor
if rectal bleeding occurs or you fail to have a bowel movement after using a laxative. This may indicate a serious condition.
If swallowed, get medical help or contact a Poison Control Center right away.
• Remove foil. Insert suppository well into rectum touching the bowel wall. Retain about 15 to 20 minutes.
• In the presence of anal fissures or hemorrhoids, suppositories should be coated at the tip with petroleum jelly.
NDC 37205-102-53
LEADER®
BISACODYL SUPPOSITORIES
LAXATIVE
FOR PROMPT RELIEF OF CONSTIPATION
12 BISACODYL SUPPOSITORIES 10 MG EACH
BISACODYL
bisacodyl suppository |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part334 | 09/10/1997 |
Labeler - CARDINAL HEALTH, INC. (097537435) |
Registrant - G&W Laboratories, Inc. (001271188) |
Establishment | |||
Name | Address | ID/FEI | Operations |
G&W Laboratories, Inc. | 001271188 | MANUFACTURE |
Revised: 03/2012 CARDINAL HEALTH, INC.